Note: Descriptions are shown in the official language in which they were submitted.
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
1
ANTIMICROBIAZ COMPOSITION CONTAINING A HAI~OPEROXIDASE, A
HYDROGEN PEROXIDE SOURCE, A HALIDE SOURCE AND AN AMMONIUM
SOURCE
The present invention relates to a very effective
enzymatic composition capable of killing or inhibiting
microbial cells or microorganisms, more specifically microbial
cells or microorganisms present in laundry, on hard surfaces,
in water systems, on skin, teeth or mucous membranes; and for
io preserving food products, cosmetics, paints, coatings, etc.
'BACKGROUND OF THE INVENTION
Various enzymatic antimicrobial compositions are known
in the art. For instance, WO 94/04127 discloses stabilized
15 dentifrice compositions which are capable of producing
antimicrobially effective concentrations of hypothiocyanite
ions. The compositions contain an oxidoreductase capable of
producing hydrogen peroxide and a peroxidase enzyme capable of
oxidizing thiocyanate ions, which are normally present in
2o saliva, to antimicrobial hypothiocyanite ions. Suitable
peroxidases include lactoperoxidase, myeloperoxidase, salivary
peroxidase and chloroperoxidase.
In EP-A-0 500 387 enzymatic antimicrobial compositions
are disclosed comprising a haloperoxidase, e.g., myelo
25 peroxidase, eosinophil oxidase, lactoperoxidase and
chloroperoxidase, which selectively binds to and inhibits the
growth of target microorganisms in the presence of peroxide
and halide.
WO 95/27046 discloses an antimicrobial composition
ao comprising a Vanadium chloroperoxidase, halide ions, and
hydrogen peroxide or a hydrogen peroxide-generating agent.
WO 96/38548 discloses an antimicrobial composition
comprising a haloperoxidase, a halide ion, a peroxide
generating agent and an amino acid type.
35 The object of the present invention is to provide a
composition for killing or inhibiting microbial cells, i.e.,
for disinfection or preservation, which is easy to use and an
effective alternative to the known disinfecting and preserving
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
2
compositions and methods.
gUI~ARY OF THE INVENTION
Surprisingly, it has been found that the combined action
s of a haloperoxidase, a hydrogen peroxide source, a halide
source and an ammonium source results in a hitherto unknown
synergistic antimicrobial effect,
Thus, based on these findings, the present invention
provides, in a first aspect, an enzymatic antimicrobial
io composition comprising a haloperoxidase, a hydrogen peroxide
source, a halide source and an ammonium source wherein said
composition results in a hitherto unknown synergistic
antimicrobial effect.
The composition of the invention is useful as antimicro
15 bial ingredient wherever such an ingredient is needed, for
example, for the preservation of food, beverages, cosmetics,
deodorants, contact lens products, food ingredients or enzyme
compositions; as a disinfectant for use, e.g., on human or
animal skin, hair, oral cavity, mucous membranes, wounds,
2o bruises or in the eye; for killing microbial cells in laundry;
and for incorporation in cleaning compositions or disin-
fectants for hard surface cleaning, for water treatment, or
for disinfection.
Accordingly, in further aspects, the present invention
as provides a method of inhibiting microorganisms present in
laundry, wherein the laundry is treated with a soaking,
washing or rinsing liquor comprising this composition; a
method of inhibiting microbial growth on a hard surface,
wherein the surface is contacted with this composition; a
3o method of inhibiting microbial cells present in industrial
water lines; and a method of killing microbial cells present
on human or animal skin, mucous membranes, teeth, wounds,
bruises or in the eye or inhibiting the growth thereof,
wherein the cells to be killed or inhibited on the skin,
35 mucous membrane, teeth, wound or bruise are/is contacted with
this composition.
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
3
BRIEF DESCRIPTION OF DRAWINGS
The present invention is further illustrated by
reference to the accompanying drawings, in which
Fig. 1 shows a calibration curve for growth of
s Pseudomonas aeruginosa ATCC 10146 in TSB at 25°C: see Example
1.
Fig. 2 shows a response surface plot for the
antibacterial activity against Staphylococcus epidermidis;
when sodium chloride and/or ammonium are added to the reaction
zo medium; see Example 1.
Fig. 3 shows the bactericidal activity of the Curvularia
haloperoxidase combined with iodide and ammonium sulphate
( KI and (NH4)2S04; -- . KI); see Example 2.
Fig. 4 shows the bactericidal activity of the Curvularia
is haloperoxidase combined with bromide and ammonium sulphate;
( KBr and (NH4)2504; -- . KBr); see Example 2.
Fig. 5 shows the bactericidal activity of the Curvularia
haloperoxidase (rCvP) combined with chloride and ethanolamine;
see Example 4.
DETAILED DESCRIPTION OF THE INVENTION
In the context of the present invention the term
"antimicrobial" is intended to mean that there is a
bactericidal and/or a bacteriostatic and/or fungicidal and/or
2s fungistatic effect and/or a virucidal effect, wherein
The term "bactericidal" is to be understood as capable
of killing bacterial cells.
The term "bacteriostatic" is to be understood as capable
of inhibiting bacterial growth, i.e. inhibiting growing bac
3o terial cells.
The term "fungicidal" is to be understood as capable of
killing fungal cells.
The term "fungistatic" is to be understood as capable of
inhibiting fungal growth, i.e. inhibiting growing fungal
35 cells.
The term "virucidal" is to be understood as capable of
inactivating virus.
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
4
The term "microbial cells" denotes bacterial or fungal
cells, and the term "microorganism" denotes a fungus
(including yeasts) or a bacterium.
In the context of the present invention the term
s "inhibiting growth of microbial cells" is intended to mean
that the cells are in the non-growing state, i.e., that they
are not able to progate.
The term "hard surface" as used herein relates to any
surface which is essentially non-permeable for microorganisms.
io Examples of hard surfaces are surfaces made from metal, e.g.,
stainless steel, plastics, rubber, board, glass, wood, paper,
textile, concrete, rock, marble, gypsum and ceramic materials
which optionally may be coated, e.g., with paint, enamel and
the like. The hard surface can also be a process equipment,
15 e.g., a cooling tower, an osmotic membrane, a water treatment
plant, a dairy, a food processing plant, a chemical or
pharmaceutical process plant. Accordingly, the composition
according to the present invention is useful in a conventional
cleaning-in-place (C-I-P) system.
_Haloperoxidases
In the context of the present invention the term
"haloperoxidase" is intended to mean an enzyme selected from
the group consisting of chloride peroxidase (EC 1.11.1.10),
2s bromide peroxidase, and iodide peroxidase (EC 1.11.1.8).
A chloride peroxidase is an enzyme capable of
oxidizing chloride, bromide and iodide ions with the
consumption of H~Oz .
A bromide peroxidase is an enzyme capable of
-oxidizing bromide and iodide ions with the consumption of H~Oz.
A iodide peroxidase is an enzyme capable of oxidizing
iodide ions with the consumption of H~O~.
According to the invention Vanadium haloperoxidases
are preferred. Vanadium peroxidases are different from other
haloperoxidases in that the prosthetic group in theses enzymes
have structural features similar to vanadate (vanadium V),
whereas the other haloperoxidases are hemeperoxidases. The
Vanadium ~haloperoxidases disclosed in WO 95/27046 are
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98100348
preferred.
Haloperoxidases form a class of enzymes which are
able to oxidize halides (X = C1-, Br-, or I-) in the presence
of hydrogen peroxide to the corresponding hypohalous acid (HOX)
s according to:
H,,O., + X- + H+ -> H20 + HOX
If an appropriate nucleophilic compound is present, a
io reaction will occur with HOX, which has an antimicrobial
effect.
Haloperoxidases have been ' isolated from various
organisms: mammals, marine animals, plants, algae, a lichen,
fungi and bacteria (for reference see Biochimica et Biophysica
Acta 1161, 1993, pp. 249-256). It is generally accepted that
haloperoxidases are the enzymes responsible for the formation
of halogenated compounds in nature, although other enzymes may
be involved.
Haloperoxidases have been isolated from many
zo different fungi, in particular from the fungus group dema
tiaceous hyphomycetes, such as Caldariomyces, e.g., C. fumago,
Alternaria, Curvularia, e.g., C. verruculosa and C. inaequalis,
Drechslera, Ulocladium and Botrytis (see US Patent No.
4, 937, 192) .
According to the present invention a haloperoxidase
obtainable from Curvularia, in particular C. verruculosa is
preferred such as C. verruculosa CBS 147.63 or C. verruculosa
CBS 444.70. Curvularia haloperoxidase and recombinant
production hereof is described in WO 97/04102.
ao Haloperoxidase has also been isolated from bacteria
such as Pseudomonas, e.g., P. pyrrocinia (for reference see The
Journal of Biological Chemistry 263, 1988, pp. 13725-13732) and
Streptomyces, e.g., S. aureofaciens (for reference see Struc-
tural Biology 1, 1994, pp. 532-537).
Bromide peroxidase has been isolated from algae (see
US Patent No. 4,937,192).
In use, the concentration of the haloperoxidase may
be varied in order to achieve the desired antimicrobial effect
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
6
in the desired time frame. However, according to the invention
the haloperoxidase will normally be added in a concentration of
0.01-100 mg enzyme protein per liter, preferably in a concen-
tration of 0.05-50 mg enzyme protein per liter, more preferably
s in a concentration of 0.5-10 mg enzyme protein per liter.
_Hydrogen Peroxide Sources
According to the invention the hydrogen peroxide
needed for the reaction with the haloperoxidase may be achieved
to in many different ways: It may be hydrogen peroxide or a
hydrogen peroxide precursor, such as, e.g., percarbonate or
perborate, or a peroxycarboxylic acid or a salt thereof, or it
may be a hydrogen peroxide generating enzyme system, such as,
e.g., an oxidase and its substrate. Useful oxidases may be,
is e.g., a glucose oxidase, a glycerol oxidase or an amino acid
oxidase. An example of an amino acid oxidase is given in WO
94/25574.
It may be advantageous to use enzymatically
generated hydrogen peroxide, since this source results in a
2o relatively low concentration of hydrogen peroxide under the
biologically relevant conditions. Low concentrations of
hydrogen peroxide result in an increase in the rate of
haloperoxidase-catalysed reaction.
According to the invention the hydrogen peroxide
2s source needed for the reaction with the haloperoxidase may be
added in a concentration corresponding to a hydrogen peroxide
concentration in the range of from 0.01-1000 mM, preferably in
the range of from 0.1-100 mM.
3o Halide Sources
According to the invention the halide source needed
for the reaction with the haloperoxidase may be achieved in
many different ways, e.g., by adding a halide salt: It may be
sodium chloride, potassium chloride, sodium bromide, potassium
35 bromide, sodium iodide, or potassium iodide.
The concentration of the halide source will typically
correspond to 0.01-1000 mM, preferably in the range of from
0.05-500 mM.
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
7
Ammonium Sources
When adding an ammonium source to the antimicrobial
composition (haloperoxidase, hydrogen peroxide, halide),
s halide amines are formed which results in a 1000 bactericidal
activity of the enzyme system.
We have thus observed that there is a synergistic
effect between the halide and the ammonium source present in
the composition (see Example l, 2 and 4).
The used ammonium source may be compounds of the
formula:
R1
HN
R2
wherein the substituent groups R1 and R2, which may be
i5 identical or different, independently represent any of the
following radicals: hydrogen, halide, sulphate, phenyl, a
straight or branched chain alkyl having from 1 to 14 carbon
atoms, or a substituted straight or branched alkyl group having
from 1 to 14 carbon atoms where the substituent group is
20 located at C3-C18 and represent any of the following radicals:
hydroxy, halogen, formyl, carboxy, and esters and salts hereof,
carbamoyl, sulfo, and esters and salts hereof, sulfamoyl,
nitro, amino, phenyl, C1-CS-alkoxy, carbonyl-Ci-C;-alkyl, aryl-
C1-C5-alkyl; which carbamoyl, sulfamoyl, and amino groups may
2s furthermore be unsubstituted or substituted once or twice with
a substituent group R3; and which phenyl may furthermore be
unsubstituted or substituted with one or more substituent
groups R3; and which C,-C14-alkyl, C1-CS-alkoxy, carbonyl-C1-CS-
alkyl, and aryl-C1-CS-alkyl groups may be saturated or
3o unsaturated, branched or unbranched, and may furthermore be
unsubstituted or substituted with one or more substituent
groups R3;
which substituent group R3 represents any of the following
radicals: halogen, hydroxy, formyl, carboxy and esters and
35 salts hereof, carbamoyl, sulfo and esters and salts hereof,
sulfamoyl; vitro, amino, phenyl, aminoalkyl, piperidino,
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
8
piperazinyl, pyrrolidin-1-yl, C1-CS-alkyl, C1-CS-alkoxy; which
carbamoyl, sulfamoyl, and amino groups may furthermore be
unsubstituted or substituted once or twice with hydroxy, C1-CS-
alkyl, C1-CS-alkoxy; and which phenyl may furthermore be
s substituted with one or more of the following radicals:
halogen, hydroxy, amino, formyl, carboxy and esters and salts
hereof, carbamoyl, sulfo and esters and salts hereof, and
sulfamoyl; and which C1-CS-alkyl, and C1-CS-alkoxy groups may
furthermore be saturated or unsaturated, branched or
io unbranched, and may furthermore be substituted once or twice
with any of the following radicals: halogen, hydroxy, amino,
formyl, carboxy and esters and salts hereof, carbamoyl, sulfo
and esters and salts hereof, and sulfamoyl;
or in which general formula the substituent groups R1-R2 may
15 together form a group -B-, in which B represents any of the
following groups: (-CHR3-N=N-), (-CH=CH-)n or (-CH=N-)n in
which groups n-represents an integer of from 1 to 3 , R3 is a
substituent group as defined. (It is to be understood that if
the above mentioned formula comprises two or more R3
2o substituent groups, these R3-substituent groups may be the
same or different).
As used herein, the ammonium compounds may be in
their cationic form.
In a preferred embodiment R1 is hydrogen.
2s In another preferred embodiment R1 is hydrogen and
R2 is an alkohol (aminoalcohol), e.g., ethanolamine.
In a further preferred embodiment the ammonium
source is an ammonium salt, i.e. any ammonium salt known in
the art : a . g . , diammonium sulphate, ammonium chloride, ammonium
3o bromide, or ammonium iodide.
According to the invention the ammonium source needed
for the reaction with the haloperoxidase may be added in a
concentration corresponding to an ammonium concentration in the
range of from 0.01-1000 mM, preferably in the range of from
35 0.05-500 mM.
The composition
CA 02298788 2000-O1-28
WO 99/08531 PCTlDK98/00348
9
The composition comprising the haloperoxidase, the
hydrogen peroxide source, the halide source, and the ammonium
source may be formulated as a solid or a liquid.
When formulated as a solid all components may be
s mixed together, e.g., as a powder, a granulate or a gelled
product.
When other than dry form compositions are used and
even in that case, it is preferred to use a two part
formulation system having the hydrogen peroxide separate from
io the other components.
The composition of the invention may further comprise
auxiliary agents such as wetting agents, thickening agents,
buffer, stabilisers, perfume, colourants, fillers and the
like.
15 Useful wetting agents are surfactants, i.e., non-ionic,
anionic, amphoteric or zwitterionic surfactants.
The composition of the invention may be a concentrated
product or a ready-to-use product. In use, the concentrated
product is typically diluted with water to provide a medium
2o having an effective antimicrobial activity, applied to the
object to be disinfected or preserved, and allowed to react
with the micro-organisms present.
The optimum pH is usually a compromise between the
optimum stability and optimum activity of the haloperoxidase
2s in question. However the invention may advantageously be
carried out at a relatively high pH, since it is contemplated
that the bacteriocidal activities are optimal at high pH
values.
The composition of the invention may also be formulated
3o as a two part system wherein one part is the haloperoxidase
and the ammonium source; the other part is the hydrogen
peroxide source; and the halide source may then come from tap
water or otherwise be naturally present.
35 Uses
The composition of the invention may be incorporated
into a detergent or cleaning composition comprising more
enzyme types useful in detergent or cleaning compositions,
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
preferably at least one further enzyme selected from the group
consisting of proteases, carbohydrases, amylases, cutinases,
peroxidases, oxidases, laccases, cellulases, xylanases, and
lipases.
When used for preservation of food, beverages, cosmetics
such as lotions, creams, gels, ointments, soaps, shampoos,
conditioners, antiperspirants, deodorants, mouth wash, contact
lens products, enzyme formulations, or food ingredients, the
composition used in the method of the present invention may be
io incorporated into the e.g. unpreserved food, beverages, cosme-
tics, contact lens products, food ingredients or
antiinflammatory product in an amount effective for killing or
inhibiting growing of microbial cells.
Thus, the composition used in the method of the invention
i5 may by useful as a disinfectant, e.g., in the treatment of
acne, infections in the eye or the mouth, skin infections; in
antiperspirants or deodorants; in foot bath salts; for clean
ing and disinfection of contact lenses, hard surfaces, teeth
(oral care), wounds, bruises and the like.
2o In general it is contemplated that the composition of the
present invention is useful for cleaning, disinfecting or
inhibiting microbial growth on any hard surface. Examples of
surfaces, which may advantageously be contacted with the
composition of the invention are surfaces of process equipment
2s used e.g, dairies, chemical or pharmaceutical process plants,
water sanitation systems, paper pulp processing plants, water
treatment plants, and cooling towers. The composition of the
invention should be used in an amount, which is effective for
cleaning, disinfecting or inhibiting microbial growth on the
3o surface in question.
Further, it is contemplated that the composition of the
invention can advantageously be used in a cleaning-in-place
(C.I.P.) system for cleaning of process equipment of any kind.
The method of the invention may additionally be used for
as cleaning surfaces and cooking utensils in food processing
plants and in any area in which food is prepared or served such
as hospitals, nursing homes, restaurants, especially fast food
restaurants, delicatessens and the like. It may also be used as
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98100348
11
an antimicrobial in food products and would be especially
useful as a surface antimicrobial in cheeses, fruits and
vegetables and food on salad bars.
It may also be used as a preservation agent or a
disinfection agent in water based paints.
The composition of the present invention is also useful
for microbial control of water lines, and for disinfection of
water, in particular for disinfection of industrial water.
to The present invention is further illustrated in the
following examples which are not in any way intended to limit
the scope of the invention as claimed.
EXAMPLE 1
Antibacterial activity of haloperoxidase against P. aeruginosa
_and S. epidermidis.
The antibacterial activity of Curvularia verruculosa
recombinant peroxidase (rCvP), produced as described in WO
97/04102, available from Novo Nordisk A/S, DK-2880 Bagsvaerd,
Denmark, has been tested with the following enhancing agents:
sodium chloride and diammonium sulphate.
The antibacterial activity of a haloperoxidase was tested
in MES-buffer (2-[N-morpholino] ethanesulfonic acid)(pH 6.0)
against Pseudomonas aeruginosa ATCC 10146 and Staphylococcus
epidermidis DSM 20 042 with sodium chloride as electron donor,
and hydrogen peroxide was added as electron acceptor in the
presence of NH4'. The cells (approximately 106 cfu/ml) were
incubated with the enzyme for 15 min at 40°C.
3o The bactericidal activity was determined by incubation in
Malthus. The detection times measured by the Malthus
instrument were converted to cfu/ml by a calibration curve.
Either direct or indirect Malthus measurements were used
when enumerating total survival cells (Malthus Flexi M2060,
Malthus Instrument Limited). By the direct measurements, the
cell metabolism was determined by conductance measurements in
the growth substrate. By the indirect measurements, 3 ml of
growth medium was transferred to the outer chamber of the
CA 02298788 2000-O1-28
PCT/DK98/00348
W O 99/08531
12
indirect Malthus cells, and 0.5 ml of sterile KOH (0.1 M) was
transferred to the inner chamber. The cell suspensions were
after enzyme treatment transferred to the outer chamber of the
Malthus cell. As cells are growing in the outer chamber they
s produce C0~ which will dissolve in the KOH in the inner chamber
and thereby change the conductance of the KOH. The amount of
C0~ formed by the respiring cells surviving the enzyme
treatment was used for estimating the number of viable cells.
When the conductance change is measurable by the Malthus,
io a detection time (dt) will be recorded. The dt~s were
converted to colony counts by use of a calibration curve
relating cfu/ml to dt (Fig. 1).
Antibacterial activity of a haloperoxidase (1 mg/1) with
NaCl was at pH 6 observed at NaCl concentrations above 20 mM,
15 the antibacterial activity increased with increasing NaCl
concentrations but a plateau was reached at approximately 100
mM (depends on pH, temperature, test strains etc.). Hydrogen
peroxide was added to a final concentration of 0.5 mM. Using
200 mM NaCl as electron donor resulted in a reduction in
20 living cells (both strains) from 106 cfu/ml to approximately
103 cfu/ml.
A significant synergistic effect was observed between
NaCl and (NHQ) ZSO~ . The combination of NaCl and (NH,) ~SOq
resulted in a 100$ lethal activity against both strains (Fig.
2s 2) at a concentration of from about 3 mM NHq'.
EXAMPLE 2
Antibacterial activity of Curvularia verruculosa recombinant
30 _haloperoxidase using different enhancing agents
The antibacterial activity of a haloperoxidase (1 mg/1)
was tested in MES-buffer (2-[N-morpholino] ethanesulfonic
acid)(pH 6.0) against Staphylococcus epidermidis DSM 20 042
with potassium iodide and potassium bromide as electron donor,
35 and hydrogen peroxide (to a final concentration of 0.5 mM) was
added as electron acceptor in the presence of NHq+. The cells
(approximately 106 cfu/ml) were incubated with enzyme for 15
min at ~40°C. The bactericidal activity was determined by
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
13
incubation in Malthus (see Example 1).
A 100 antibacterial activity of the haloperoxidase
combined with iodide was determined at a iodide concentration
of about 0.2 mM. If ammonium was added, a 1000 bactericidal
s activity was determined already at a concentration of about
0.05 - 0.1 mM iodide (Fig. 3).
A high concentration of bromide (> 10 mM) was needed for
1000 bactericidal activity, but the combination of bromide and
ammonium ions resulted in a 1000 bactericidal activity at a
to bromide concentration of above 2.5 mM (Fig. 4).
EXA~I~E 3
Antibacterial activity of Curvularia verruculosa recombinant
15 haloperoxidase using ammonium halides as electron donors
The antibacterial activity of a haloperoxidase (1 mg/1)
was tested in MES-buffer (2-[N-morpholino] ethanesulfonic
acid)(pH 6.0) against Staphylococcus epidermidis DSM 20 042
with ammonium iodide, ammonium chloride or ammonium bromide as
2o electron donors, and hydrogen peroxide was added as electron
acceptor giving the final concentration 0.5 mM. The cells
(approximately 106 cfu/ml) were incubated with enzyme for 15
min at 40°C. The bactericidal activity was determined by
incubation in Malthus (see Example 1).
2s The concentration of ammonium halides which is needed for
antibacterial activity, is below the concentration of
potassium or sodium halides needed for the same activity
(Table 1) .
3o Table 1: Bactericidal activity against S. epidermidis. The
electron donor is added either as a potassium or sodium salt
or an ammonium salt.
oncen ra ion o'~a i a og re uc ion in ce. num er
(log cfu/ml)
INH4:
0.25 6.2
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
14
It can be seen from Table 1 that if the salt is an
ammonium halide salt such as ammonium iodide, ammonium
chloride, or ammonium bromide a 1000 bactericidal activity is
s possible. So the halide- and the ammonium- source may be one
and the same, but normally the optimum concentrations of the
halide and the ammonium will be at different levels.
EXAMPLE 4
io
Synergistic antibacterial activity of Curvularia verruculosa
recombinant haloperoxidase (rCvP) using ethanolamine in
combination with halides
The antibacterial activity of Curvularia verruculosa
i5 haloperoxidase (1 mg/L) was tested in HEPES-buffer (Sigma
H3375)(pH 7.0) against Staphylococcus epidermidis DSM 20 042
with chloride (80 mM) as electron donor combined with
ethanolamine (2.5 mM), and hydrogen peroxide was added as
electron acceptor giving the final concentration 0.5 mM. The
2o synergistic effects were found by using a 24 factorial design.
The cells (approximately 106 cfu/ml) were incubated with enzyme
for 15 min at 40°C. The bactericidal activity was determined
by incubation in Malthus (see Example 1).
Addition of ethanolamine significantly increased the
2s activity of the enzyme system (see Fig. 5). Thus, a 1000 kill
CA 02298788 2000-O1-28
WO 99/08531 PCT/DK98/00348
was obtained against Staphylococcus epidermidis when
ethanolamine was added, whereas a cell reduction of
approximately 3 log units was observed when no ethanolamine
was added.
s
